| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 82,260,000 | 74,457,000 | 64,028,000 | 84,696,000 | | Cost of Revenue | 36,823,000 | 57,544,000 | 36,124,000 | 47,926,000 | | | Gross Profit | 45,437,000 | 16,913,000 | 27,904,000 | 36,770,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,908,000 | 6,049,000 | 17,154,000 | 19,676,000 | | Non Recurring | 1,336,000 |
-
|
-
|
-
| | Others | 2,927,000 | 3,004,000 | 2,793,000 | 3,177,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,266,000 | 7,860,000 | 7,957,000 | 13,917,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,266,000 | 7,860,000 | 7,957,000 | 13,313,000 | | Interest Expense | 62,000 | 343,000 | 107,000 | 118,000 | | Income Before Tax | 9,204,000 | 7,517,000 | 7,850,000 | 13,195,000 | | Income Tax Expense | 4,333,000 | 3,571,000 | 3,148,000 | 5,375,000 | | Minority Interest | (141,000) | (148,000) |
-
| (604,000) | | | | Net Income From Continuing Ops | 4,730,000 | 3,798,000 | 4,702,000 | 7,820,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,730,000 | 3,798,000 | 4,702,000 | 7,820,000 | | Preferred Stock And Other Adjustments |
-
| 152,000 | (152,000) |
-
| | | Net Income Applicable To Common Shares | $4,730,000 | $3,950,000 | $4,550,000 | $7,820,000 |
|
0.29% Nasdaq 
Income Statement
